This may impede the loss of podocytes, which in turn improves glycolipid metabolism (AST, LDH), inflammation (IL-6) and oxidative stress (HO-1), as well as the fibrinogen system (tPA, PAI-1) that accompanies diabetic nephropathy (Figure 7). This evidence concerns the gene HMOX1 and diabetic kidney disease.